Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.

View ICR - OIRA Conclusion

OMB Control No: 0938-0936	ICR Reference No: 202109-0938-003
Status: Historical Active	Previous ICR Reference No: 202101-0938-001
Agency/Subagency: HHS/CMS	Agency Tracking No: CM-CPC
Title: Solicitation for Applications for Medicare Prescription Drug Plan 2023 Contracts (CMS-10137)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 08/24/2022
Retrieve Notice of Action (NOA)	Date Received in OIRA: 10/27/2021
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2024	36 Months From Approved	07/31/2024
Responses	382	0	331
Time Burden (Hours)	1,716	0	1,550
Cost Burden (Dollars)	0	0	0

Authorizing Statute(s): Statute at Large: 18 Stat. 1860
   PL: Pub.L. 111 - 148 3314 Name of Law: Including cost incurred by AIDS drug assistance programs and Indian Health services
   PL: Pub.L. 111 - 148 3310 Name of Law: Reducing Wasteful dispensing of outpatient drugs in LTC facilities
   PL: Pub.L. 111 - 148 6005 Name of Law: Pharmacy benefit managers transparency requirements
   PL: Pub.L. 108 - 173 1860D Name of Law: Medicare Prescription Drug Benefit Program

Citations for New Statutory Requirements: None

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	382	331	51
Annual Time Burden (Hours)	1,716	1,550	166
Annual Cost Burden (Dollars)	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The estimated time for completing the prescription drug applications is 1,715.99 hours. This is a 166.44 hour increase from the estimate of 1,549.55 hours for the 2022 prescription drug application. However, the actual number of 2022 applicants was much higher than anticipated and, so the burden for the number of applications received for 2022 was 1,719.66, hours, 170.11 hours more than the estimated burden for 2022. This increase was due to an increase in the burden per applicant and two substantive changes to the application for 2022. One attestation was added for an organization to verify that they are organized under the laws of a state. Another attestation was split into two attestations, so organizations can verify separately whether they are affected by the restrictions in 42 CFR §423.509 or the restrictions in 42 CFR §§ 423.507, 423.508, or 423.510. This added .04 hours (approximately 2 minutes) to the time it takes to complete an initial application.

Annual Cost to Federal Government: $140,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Yes

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Stephan McKenzie 410 786-1943 stephan.mckenzie@cms.hhs.gov